MedTrace Logo

Translation and Validation of the French mPCOSQ (mPCOSQ-F).

NCT07016035 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-08-07

No results posted yet for this study

Summary

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.

The first stage of the study consisted in translating the questionnaire from English to French.

Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

Conditions

  • Polycystic Ovary Syndrome Health-related Quality of Life

Interventions

OTHER

mPCOSQ-F and SF-36

Questionnaires

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2027-05-12
Completion
2027-05-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07016035 on ClinicalTrials.gov